PTJ
MCRB icon

Paul Tudor Jones’s Seres Therapeutics MCRB Stock Holding History

Paul Tudor Jones’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,099
Closed -$43.4K – 3558
2025
Q1 		$43.4K Hold
3,099
– – ﹤0.01% 2963
2024
Q4 		$51.5K Hold
3,099
– – ﹤0.01% 2930
2024
Q3 		$58.6K Hold
3,099
– – ﹤0.01% 2617
2024
Q2 		$44.9K Hold
3,099
– – ﹤0.01% 2231
2024
Q1 		$48K Hold
3,099
– – ﹤0.01% 2116
2023
Q4 		$86.8K Sell
3,099
-1,259
-29% -$33.1K ﹤0.01% 2251
2023
Q3 		$207K Buy
+4,358
New +$333K ﹤0.01% 2080
2023
Q2 		– Sell
-3,330
Closed -$378K – 2740
2023
Q1 		$378K Buy
+3,330
New +$360K 0.01% 1782
2019
Q1 		– Sell
-595
Closed -$54K – 1205
2018
Q4 		$54K Sell
595
-182
-23% -$25.5K ﹤0.01% 954
2018
Q3 		$118K Sell
777
-297
-28% -$48.1K ﹤0.01% 1014
2018
Q2 		$185K Sell
1,074
-912
-46% -$149K 0.01% 941
2018
Q1 		$292K Sell
1,986
-175
-8% -$33.6K 0.01% 746
2017
Q4 		$438K Buy
2,161
+546
+34% +$112K 0.01% 661
2017
Q3 		$518K Buy
1,615
+484
+43% +$132K 0.01% 626
2017
Q2 		$256K Sell
1,131
-1,378
-55% -$283K 0.01% 807
2017
Q1 		$566K Buy
2,509
+1,553
+162% +$315K 0.02% 614
2016
Q4 		$189K Sell
956
-707
-43% -$154K ﹤0.01% 1238
2016
Q3 		$409K Buy
+1,663
New +$583K 0.01% 843
2015
Q3 		– Sell
-750
Closed -$623K – 1664
2015
Q2 		$623K Buy
+750
New +$655K 0.02% 650

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Paul Tudor Jones's MCRB Position: Q2 2025 in Review

Paul Tudor Jones sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 3,099 shares — an estimated $43.4K sold.

Paul Tudor Jones first reported a position in MCRB in Q2 2015 and held it in 19 quarters. The position peaked at $623K in Q2 2015. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.

  • Paul Tudor Jones reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 3,099 Seres Therapeutics shares in Q2 2025, an estimated $43.4K.
  • Paul Tudor Jones first reported a position in Seres Therapeutics in Q2 2015 and held it in 19 quarters.
  • Paul Tudor Jones's Seres Therapeutics position peaked at $623K in Q2 2015.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.